Kukje to launch Novasc generic

Published: 2008-01-21 06:59:00

Updated: 2008-01-21 06:59:00

Kukje Pharm says it plans to market amlodipine 5 mg as Pfizer's Novasc generic drug from January 21, despite the current patent lawsuit over amlodipne between Pfizer Korea and Ahngook Pharm.

We decided to launch amlodipine preparations as it gets listed for insurance coverage and Ahngook is ex...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK